Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | DGKA | P23743 | 2/20 | 0.55 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514724 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL514908 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL3694489 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL6434039 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL15758052 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL514827 | 0.94 | TSHR (0.53) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL514530 | 0.91 | TSHR (0.59) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL514084 | 0.89 | TSHR (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL14763919 | 0.89 | TSHR (0.62) | ALDH1A1LMNATSHRDGKAMGLL | |
| SCHEMBL3123509 | 0.89 | TSHR (0.62) | ALDH1A1LMNATSHRDGKAMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102369173-B | Method for producing high-purity terminal olefin compound | KURARAY CO | 2014-09-10 | — | — | CN | disclosed |
| EP-2415740-B1 | METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND | KURARAY CO (JP) | 2013-12-25 | — | — | EP | disclosed |
| US-8609886-B2 | Method for producing high purity terminal olefin compound | KURARAY CO., LTD. (JP) | 2013-12-17 | — | — | US | disclosed |
| CN-102369173-A | Method for producing high-purity terminal olefin compound | KURARAY CO | 2012-03-07 | — | — | CN | disclosed |
| EP-2415740-A1 | METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND | Kuraray Co., Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120029229-A1 | METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND | KURARAY CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029229-A1 | METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND | ADH1A, ADH1C, OSBP | ALDH1A1 233/4885LMNA 3696/4885TSHR 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.